AI assistant
Sending…
RELMADA THERAPEUTICS, INC. — Director's Dealing 2019
Oct 21, 2019
34465_dirs_2019-10-21_2dff9837-58ca-4223-a716-385afc4d52eb.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RELMADA THERAPEUTICS, INC. (RLMD)
CIK: 0001553643
Period of Report: 2019-10-21
Reporting Person: Shenouda Maged (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-10-21 | Common Stock | P | 978 | $23.00 | Acquired | 2228 | Direct |
More from RELMADA THERAPEUTICS, INC.
Declaration of Voting Results & Voting Rights Announcements
2026
May 28
Share Issue/Capital Change
2026
May 13
Regulatory Filings
2026
May 12
Capital/Financing Update
2026
Apr 9
Regulatory Filings
2026
Mar 20
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 12
Capital/Financing Update
2026
Jan 30
Director's Dealing
2025
Dec 16